XBiotech (XBIT) Net Cash Flow (2014 - 2025)
XBiotech (XBIT) posted quarterly Net Cash Flow of -$23.0 million for Q4 2025, down 262.5% year-over-year from $14.1 million in Q4 2024, and down 426.12% quarter-over-quarter from -$4.4 million in Q3 2025.
XBiotech (XBIT) Net Cash Flow (2014 - 2025) Analysis & Trends
XBiotech's Net Cash Flow history runs 12 years deep, the most recent figure standing at -$23.0 million for Q4 2025.
- In Q4 2025, Net Cash Flow fell 262.5% year-over-year to -$23.0 million; the TTM figure through Dec 2025 stood at -$50.5 million (down 131.28% YoY), while the FY2025 annual figure was -$50.5 million, down 131.28% from the prior year.
- Net Cash Flow for Q4 2025 stood at -$23.0 million, down from -$4.4 million in the prior quarter.
- The five-year high for Net Cash Flow was $75.1 million in Q2 2021, with the low at -$76.1 million in Q3 2021.
- The 5-year median for Net Cash Flow is -$5.8 million (2022), against an average of -$5.5 million.
- Peak annual rise in Net Cash Flow reached 740.67% in 2021, while the deepest fall reached 944.23% in 2021.
- XBiotech's Net Cash Flow stood at -$2.2 million in 2021, then tumbled by 221.12% to -$7.1 million in 2022, then surged by 49.82% to -$3.5 million in 2023, then slumped by 78.72% to -$6.3 million in 2024, then sank by 262.5% to -$23.0 million in 2025.
- Business Quant data shows XBIT's Net Cash Flow at -$23.0 million in Q4 2025, -$4.4 million in Q3 2025, and -$6.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -496,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -37.14 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 225.59 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2.83 Bn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.99 Mn |
| Dec 31, 2025 | -22.99 Mn |
| Sep 30, 2025 | -4.37 Mn |
| Sep 30, 2025 | -4.37 Mn |
| Jun 30, 2025 | -6.04 Mn |
| Jun 30, 2025 | -6.04 Mn |
| Mar 31, 2025 | -17.06 Mn |
| Mar 31, 2025 | -17.06 Mn |
| Dec 31, 2024 | -6.34 Mn |
| Dec 31, 2024 | -6.34 Mn |
| Sep 30, 2024 | -6.12 Mn |
| Sep 30, 2024 | -6.12 Mn |
| Jun 30, 2024 | -11.96 Mn |
| Jun 30, 2024 | -11.96 Mn |
| Mar 31, 2024 | 2.60 Mn |
| Mar 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | -3.55 Mn |
| Dec 31, 2023 | -3.55 Mn |
| Sep 30, 2023 | 60.34 Mn |
| Sep 30, 2023 | 60.34 Mn |